is there a generic glp-1 Victoza: The First Receptor Agonist FDA Announcement: The First Generic

Risk of Retained Gastric Contents in Patients Using GLP-1RAs or Tirzepatide Presenting for Endoscopy or General Anesthesia Retrospective studies suggest that individuals on GLP-1-based therapy (exenatide, liraglutide, dulaglutide, semaglutide, or tirzepatide) appear to be at an increased risk of having retained gastric contents [Supplementary Table S3 (21)

Are protein bars and shakes a good idea

& Uchigata, Y

The same day Chipotle announced its High-Protein Menu, Shake Shack introduced its own Good Fit Menu with a range of options for vegetarians, gluten-intolerant diners, protein-seekers and GLP-1 users

Based on results from the Phase II NOBILITY and Phase III REGENCY studies, nearly 46.4% of patients achieved a complete renal response when Gazyva was combined with standard therapy